Pressteck S.p.A.

What they make

1 input Pressteck S.p.A. supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Concentration2024

  The global pressurized metered-dose inhaler (pMDI) canister market — the aluminum pressure vessels inside virtually every asthma and COPD inhaler on earth — is served by essentially two specialist manufacturers: Presspart (a UK company, part of Consort Medical / Aesica Pharmaceuticals) and Pressteck S.p.A. (Italy). Together they supply the canisters for approximately 10-12 billion MDI doses delivered annually worldwide to the ~300 million people with asthma and COPD. This is among the most concentrated supply chains in global medicine: a product that is required every few hours by millions of asthma patients in acute episodes is manufactured by two companies on two different European production lines. A production disruption at either Presspart or Pressteck would immediately affect global inhaler supply, as pharmaceutical companies cannot easily substitute canisters across the two manufacturers (each canister design is validated and drug-specific; regulatory re-approval is required for canister switches).

  Pressteck S.p.A. ↗

• Did you know2023

  The deep-drawn aluminum canister technology that Pressteck uses to make pharmaceutical MDI inhalers is fundamentally the same manufacturing process as consumer aerosol cans for deodorant, hairspray, and household products. The difference between an MDI pharmaceutical canister (sold for ~$0.80-1.50 each) and a consumer aerosol can (sold for ~$0.05-0.15 each) is not the metalforming process but the material specifications (pharmaceutical-grade 1xxx or 3xxx series aluminum vs. commercial grade), interior coating requirements (PTFE or plasma coating for MDI vs. bare or lacquer for consumer), dimensional tolerances (tighter for MDI valve seating), and quality documentation (pharma GMP compliance vs. standard industrial). During supply emergencies, the line between pharmaceutical canister manufacturing and consumer aerosol manufacturing becomes porous: the same aluminum slug suppliers, deep-drawing equipment manufacturers, and metalforming expertise underlie both industries. Pressteck's pharmaceutical precision canister manufacturing sits atop the same industrial base as the commodity aerosol can industry.

  Aerosol Research Institute (ARI) ↗

• Origin2024

  Pressteck S.p.A. emerged as a specialist MDI canister manufacturer in Italy's precision metalworking industrial cluster — a sector concentrated in northern Italy's Emilia-Romagna, Lombardia, and Veneto regions, where generations of skilled metalformers for automotive, packaging, and industrial applications built a dense ecosystem of precision manufacturing expertise. Italian metalforming companies that originally served automotive stamping, precision part fabrication, and industrial packaging increasingly adapted their deep-draw aluminum capabilities for pharmaceutical applications as MDI inhaler volumes grew. The Italian pharmaceutical packaging sector benefits from proximity to major European pharmaceutical manufacturers (Chiesi Farmaceutici in Parma, Recordati in Milan, and others) and the established Italian expertise in precision aluminum and stainless steel forming. Pressteck's positioning as the main alternative to UK-based Presspart means that a UK supply disruption (Brexit supply chain impacts, floods, industrial action) and an Italian supply disruption are effectively the two scenarios that matter for global MDI canister supply continuity. [verify: Pressteck real MDI canister maker (actually Sardinia not N.Italy); alt to Presspart sound]

  Pressteck S.p.A. ↗